[Asia Economy Reporter Ji Yeon-jin]
▲HumanN = Seoul Bankruptcy Court approves rehabilitation plan
▲GW Biotech = Withdrawal of decision on third-party allotment paid-in capital increase
▲RF Tech = Contract signed for sale of 4,620,446 shares (14.40% stake) held by major shareholder Jayjun Cosmetic to Ido Healthcare
▲NK Max = Grace period granted for designation as an unfaithful disclosure corporation due to failure to disclose
▲Jinyang Pharmaceutical = Decision to acquire treasury shares worth 1 billion KRW to stabilize stock price
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- No Cure in Sight... '105 Deaths' Spark Fears as American Also Infected
- "It's Only May, but Convenience Stores Know... Iced Americano at 24°C, Tube Ice Cream at 31°C: The Thermometer of the Summer Sales Boom"
- [Exclusive] Fiscal Management Strategy Committee Elevated to Ministerial Level... Establishing an Inter-Ministerial "Fiscal Control Tower"
- [Breaking] Chung Yongjin Apologizes for Starbucks 'Tank Day' Controversy: "I Take Full Responsibility"
▲JSCO Holdings = Nine creditors file provisional injunction lawsuit to inspect accounting books and documents
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.